United Drug acquires Bilcare clinical trials materials business

20 August 2012

Ireland-based health care services company United Drug (UDG: IR) announced yesterday that it has reached agreement to acquire the UK and US clinical services businesses Bilcare Global Clinical Supplies (Bilcare GCS) from Bilcare Limited for a total consideration of $61 million.

The acquisition is expected to complete on August 31, 2012, subject to the fulfilment of usual closing conditions. As part of this agreement, Bilcare Limited will retain its clinical supplies business in Asia.

Transaction highlights

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical